Physician profile
James Robert Barrett
NPI 1285088591
$7,281.03
in general payments reported to CMS, 2019-2025
9 companies · $1,738 in 2025
The $1,738 reported for 2025 was more than what 80% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $3,015 · 2024: $2,528 · 2025: $1,738.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,500 · Travel and Lodging: $1,270 · Food and Beverage: $463 · Long Term Medical Supply Or Device Loan: $47.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,500.00 |
| Travel and Lodging | $1,269.61 |
| Food and Beverage | $463.48 |
| Long Term Medical Supply Or Device Loan | $47.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,797.61 | 2023-2025 | Davinci Xi |
| Davol INC. | $170.18 | 2024-2025 | Phasix Mesh, Arista Ah Flexitip, Arista |
| Tela Bio, INC. | $135.05 | 2024 | Ovitex 2s |
| Integra Lifesciences Corporation | $47.94 | 2025 | Cytal |
| Pacira Pharmaceuticals Incorporated | $38.55 | 2024 | Iovera |
| Ethicon US, LLC | $31.40 | 2023-2025 | Echelon; Endopath, Echelon Circular, Vistaseal |
| Acera Surgical, INC. | $27.26 | 2025 | Restrata Wound Matrix |
| Vertex Pharmaceuticals Incorporated | $17.79 | 2025 | |
| Teleflex LLC | $15.25 | 2024 | Quikclot |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Barrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.